Literature DB >> 10874689

Therapeutic time window in the penumbra during permanent focal ischemia in rats: changes of free fatty acids and glycerophospholipids.

K Narita1, M Kubota, M Nakane, S Kitahara, T Nakagomi, A Tamura, H Hisaki, H Shimasaki, N Ueta.   

Abstract

To better define a therapeutic time window for reducing the extent of damage in ischemic penumbra, the time courses of changes in the glycerophospholipid and free fatty acid (FFA) levels were determined in the rat cerebral cortex following induction of the permanent focal ischemia. Focal ischemia induced a biphasic increase in FFA levels in the cerebral cortex, which had been recognized as the ischemic penumbra during the early stages after permanent occlusion of the middle cerebral artery (MCA). The first increase in FFA levels, in which the polyunsaturated fatty acid (PUFA) contained a large number of arachidonic acid (C20:4) molecules, began at 30 min and reached a peak at 1 h, followed by transient return to each sham level 2-6 h after the onset of MCA occlusion. Thereafter, the delayed increase in FFA levels, showing more increases of docosahexaenoic acid (C22:6) molecules than the C20:4 in PUFA compositions, occurred at 24 h. In contrast, the levels of phosphatidylinositol 4-phosphate (PIP) and phosphatidylinositol 4,5-bisphosphate (PIP2) decreased rapidly at 30 min of ischemia and returned transiently to each sham level at 1-6 h. The levels of phosphatidylcholine (PC) and phosphatidylethanolamine (PE), including polyphosphoinositides (PIPs), began to decrease significantly during the late stages, i.e., 24 h after induction of ischemia. These results suggest that the time-dependent changes in FFA and PIPs levels during the early stages of ischemia (until 6 h after induction) might be an important determinant of the subsequent neuronal death in the ischemic penumbra and that the breakdown of glycerophospholipids in the later stages after the induction of focal ischemia was associated with the development of infarction in the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874689     DOI: 10.1080/01616412.2000.11740689

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke.

Authors:  Puja Garg; R Scott Duncan; Simon Kaja; Alexander Zabaneh; Kent D Chapman; Peter Koulen
Journal:  Neurosci Lett       Date:  2011-02-04       Impact factor: 3.046

Review 2.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

Review 3.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

Review 4.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

5.  Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment.

Authors:  Michaela C Pascoe; David W Howells; David P Crewther; Nicki Constantinou; Leeanne M Carey; Sarah S Rewell; Giovanni M Turchini; Gunveen Kaur; Sheila G Crewther
Journal:  Front Neurol       Date:  2014-02-06       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.